Study shows that antidepressants may reduce likelihood of testing positive for COVID-19
A new study from King's College London has found that patients who are prescribed antidepressants are significantly less likely to test for COVID-19.
Stay updated with breaking news from King Io. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A new study from King's College London has found that patients who are prescribed antidepressants are significantly less likely to test for COVID-19.
New research led by the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King's College London has found that community mental health patients who were prescribed antidepressants were significantly less likely to test positive for COVID-19 when admitted to inpatient care.
New research led by the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London has found that community mental health patients who were prescribed antidepressants were significantly less likely to test positive for COVID-19 when admitted to inpatient care.
Research suggests that microorganisms living in the gut have a role to play in the regulation of mood.
A new study published 14 June in JAMA Psychiatry has found evidence that supplementing the diet with a probiotic blend containing 14 strains of bacteria can help individuals who are being treated for major depressive disorder with antidepressants. The research, led by the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King's College London and in partnership with ADM Protexin, part of ADM, demonstrated the potential of probiotic supplementation to support improvements in multiple depression and anxiety scores over an eight-week period.